Clinical Trial: A Study to Better Understand the Biological and Molecular Mechanisms Involved in Glioblastoma Recurrence and Progression

U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07173829) titled 'A Study to Better Understand the Biological and Molecular Mechanisms Involved in Glioblastoma Recurrence and Progression' on Aug. 02, 2023.

Brief Summary: BORDEAUX-GLIO is a prospective, monocentric study which will describe the molecular, immune and metabolic pathways involved in the progression and relapse of glioblastoma, using blood and tumor samples from patients who have undergone surgery for newly diagnosed or recurrent glioblastoma in the center.

Study Start Date: Sept., 2025

Study Type: OBSERVATIONAL

Condition: Glioblastoma

Intervention: OTHER: samples

A 50 ml blood sample will be taken from the patient before the o...